Pliant Therapeutics
Patents, Design & Utilities
Last updated:
List of all Pliant Therapeutics patents 16 in total
Status | Patent |
---|---|
Grant | Utility: Amino acid compounds with unbranched linkers and methods of use Filling date: 6 Sep 2025 Issue date: 26 Jul 2022 |
Application | Utility: INTEGRIN INHIBITOR AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: AMINO ACID COMPOUNDS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Grant | Utility: Substituted amino acids as integrin inhibitors Filling date: 6 Sep 2025 Issue date: 23 Nov 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR ACTIVATION OF INTEGRINS Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: AMINO ACID COMPOUNDS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: AMINO ACID COMPOUNDS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: DOSAGE FORMS AND REGIMENS FOR AMINO ACID COMPOUNDS Filling date: 6 Sep 2025 Issue date: 12 Nov 2020 |
Grant | Utility: Amino acid compounds and methods of use Filling date: 6 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Amino acid compounds and methods of use Filling date: 6 Sep 2025 Issue date: 30 Jun 2020 |
Application | Utility: AMINO ACID COMPOUNDS WITH UNBRANCHED LINKERS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: AMINO ACID COMPOUNDS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Grant | Utility: N-acyl amino acid compounds and methods of use Filling date: 6 Sep 2025 Issue date: 31 Mar 2020 |
Application | Utility: AMINO ACID COMPOUNDS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: AMINO ACID COMPOUNDS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 12 Sep 2019 |
Showing 1 to 16 of 16 patents.